HURLY STEPHEN A 4
4 · LAVA Therapeutics NV · Filed Feb 18, 2025
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorChief Executive Officer
Transactions
- Award
Share Options (Right to Buy)
2025-02-13+335,100→ 335,100 totalExercise: $0.93Exp: 2035-03-12→ Common Shares (335,100 underlying)
Footnotes (1)
- [F1]The shares underlying the option vest in 48 equal monthly installments beginning on March 13, 2025, provided the Reporting Person remains in a service relationship with the Issuer or a subsidiary of the Issuer on each such vesting date.